Frazier Healthcare Partners Announces Strategic Minority Investment from Petershill at Goldman Sachs Alternatives
Frazier Healthcare Partners, a Seattle-based healthcare-focused private capital firm, has secured a passive minority investment from Petershill at Goldman Sachs Alternatives. The investment comes after Frazier's recent closure of its flagship fund, Frazier Healthcare Growth Buyout Fund XI, which reached its hard cap of $2.3 billion in partner commitments within six months.
Founded in 1991, Frazier has invested in over 200 companies across 34 years. The strategic investment will support Frazier's platform growth, enable increased general partner investment in existing and new funds, and provide greater balance sheet flexibility for strategic initiatives. The transaction will not impact Frazier's day-to-day management or investment approach.
Frazier Healthcare Partners, una società di capitali privati focalizzata sulla sanità con sede a Seattle, ha ottenuto un investimento passivo di minoranza da Petershill di Goldman Sachs Alternatives. L'investimento arriva dopo la recente chiusura del fondo principale di Frazier, Frazier Healthcare Growth Buyout Fund XI, che ha raggiunto il suo limite massimo di 2,3 miliardi di dollari in impegni da parte dei partner in sei mesi.
Fondata nel 1991, Frazier ha investito in oltre 200 aziende in 34 anni. L'investimento strategico supporterà la crescita della piattaforma di Frazier, consentirà un aumento degli investimenti dei partner generali in fondi esistenti e nuovi, e fornirà una maggiore flessibilità patrimoniale per iniziative strategiche. La transazione non influenzerà la gestione quotidiana o l'approccio agli investimenti di Frazier.
Frazier Healthcare Partners, una firma de capital privado enfocada en el sector salud con sede en Seattle, ha asegurado una inversión pasiva de minoría de Petershill de Goldman Sachs Alternatives. La inversión llega tras el reciente cierre de su fondo insignia, Frazier Healthcare Growth Buyout Fund XI, que alcanzó su límite máximo de 2.3 mil millones de dólares en compromisos de socios en seis meses.
Fundada en 1991, Frazier ha invertido en más de 200 empresas a lo largo de 34 años. La inversión estratégica apoyará el crecimiento de la plataforma de Frazier, permitirá un aumento en la inversión de los socios generales en fondos existentes y nuevos, y proporcionará una mayor flexibilidad en el balance para iniciativas estratégicas. La transacción no afectará la gestión diaria ni el enfoque de inversión de Frazier.
프레이저 헬스케어 파트너스, 시애틀에 본사를 둔 헬스케어 중심의 사모펀드 회사가 골드만 삭스 얼터너티브스의 피터힐로부터 수동적 소수 투자금을 확보했습니다. 이 투자는 프레이저의 주요 펀드인 프레이저 헬스케어 성장 인수 펀드 XI가 파트너의 약속으로 23억 달러의 한도에 도달한 후 이루어졌습니다.
1991년에 설립된 프레이저는 34년 동안 200개 이상의 회사에 투자해왔습니다. 이 전략적 투자는 프레이저의 플랫폼 성장 지원, 기존 및 신규 펀드에 대한 일반 파트너 투자 증가, 전략적 이니셔티브를 위한 재무 유연성을 제공할 것입니다. 이 거래는 프레이저의 일상적인 관리나 투자 접근 방식에 영향을 미치지 않을 것입니다.
Frazier Healthcare Partners, une société de capital-investissement axée sur le secteur de la santé basée à Seattle, a sécurisé un investissement passif de minorité de Petershill de Goldman Sachs Alternatives. Cet investissement intervient après la récente clôture de son fonds phare, Frazier Healthcare Growth Buyout Fund XI, qui a atteint son plafond dur de 2,3 milliards de dollars en engagements de partenaires en six mois.
Fondée en 1991, Frazier a investi dans plus de 200 entreprises au cours de 34 ans. Cet investissement stratégique soutiendra la croissance de la plateforme de Frazier, permettra une augmentation des investissements des partenaires généraux dans des fonds existants et nouveaux, et offrira une plus grande flexibilité de bilan pour des initiatives stratégiques. La transaction n'affectera pas la gestion quotidienne ou l'approche d'investissement de Frazier.
Frazier Healthcare Partners, eine auf Gesundheitswesen fokussierte Private-Equity-Firma mit Sitz in Seattle, hat eine passive Minderheitsbeteiligung von Petershill bei Goldman Sachs Alternatives gesichert. Die Investition erfolgt nach dem kürzlichen Abschluss ihres Hauptfonds, Frazier Healthcare Growth Buyout Fund XI, der innerhalb von sechs Monaten sein Hard Cap von 2,3 Milliarden Dollar an Partnerverpflichtungen erreicht hat.
Gegründet im Jahr 1991, hat Frazier in über 200 Unternehmen in 34 Jahren investiert. Die strategische Investition wird das Wachstum der Plattform von Frazier unterstützen, eine erhöhte Investition der General Partner in bestehende und neue Fonds ermöglichen und eine größere Flexibilität der Bilanz für strategische Initiativen bieten. Die Transaktion wird die tägliche Verwaltung oder den Investitionsansatz von Frazier nicht beeinflussen.
- Successfully raised $2.3B fund (FHGB XI) within 6 months, reaching hard cap
- Strategic investment from Goldman Sachs' Petershill provides additional growth capital
- Enhanced balance sheet flexibility for future strategic initiatives
- None.
Insights
Goldman Sachs continues to execute its alternative investments strategy with Petershill's minority stake in Frazier Healthcare Partners. This investment enables Goldman to capture fee streams and potential carried interest from Frazier's healthcare-focused funds without direct operational involvement.
The timing is opportunistic, following Frazier's successful
For Goldman, this represents incremental growth in its alternatives business, which typically generates higher-margin fee income compared to traditional investment banking. The strategic value lies in Goldman's continued diversification toward more stable revenue streams while gaining specialized healthcare sector exposure.
This transaction follows Petershill's established playbook of making minority investments in successful alternative managers. The passive nature means Goldman gains economic benefits without assuming direct investment risk or operational responsibilities.
Given the undisclosed investment size and passive nature, this deal alone is unlikely to materially impact Goldman's near-term financial performance, though it incrementally strengthens the firm's alternatives platform and healthcare sector positioning.
Founded in 1991, Frazier Healthcare Partners (“Frazier”) has invested in more than 200 companies over 34 years. The firm recently closed its latest flagship fund, Frazier Healthcare Growth Buyout Fund XI, L.P. (“FHGB XI”), which was significantly oversubscribed, reaching its hard cap of
Petershill specializes in minority investments in leading alternative asset managers. The group targets well-established firms with strong track records and meaningful cash flow generation, supporting their growth across future fund and product offerings.
This passive minority investment will support the continued growth of the Frazier investment platform, enable increased investment by the general partner in existing and new funds and the development of strategic initiatives by affording greater balance sheet flexibility. The transaction will not affect Frazier’s day-to-day management or investment approach.
“Over the past three decades, we have been dedicated to building market-leading healthcare companies and delivering exceptional value to business owners and investors,” said Nader Naini, Co-Managing Partner at Frazier. “We are excited to partner with Petershill, a recognized leader in global private capital markets. Their investment opens new doors globally and represents a significant milestone in the evolution of our platform at a time of immense opportunity.”
"We are thrilled to partner with Frazier, one of the leading dedicated healthcare private equity platforms in the world,” said Ali Raissi-Dehkordy, global co-Head of Petershill at Goldman Sachs Alternatives. "Frazier is a world-class institutional firm that possesses a remarkable depth of expertise, strong investment track record, differentiated value-creation capabilities, and a strategic industry network which gives us confidence in Frazier's continued growth and success."
Houlihan Lokey served as financial advisor to Frazier in connection with the transaction. Kirkland & Ellis served as legal advisor to Frazier. Fried, Frank, Harris, Shriver & Jacobson LLP served as legal advisor to Petershill.
About Frazier
Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over
About Petershill at Goldman Sachs Alternatives
Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over
The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets.
The alternative investments platform is part of Goldman Sachs Asset Management, which delivers investment and advisory services across public and private markets for the world’s leading institutions, financial advisors and individuals. Goldman Sachs Asset Management has over
Established in 2007, Petershill at Goldman Sachs Alternatives partners with leading alternative asset managers and helps to accelerate their strategic development. Petershill’s minority investments seek to support the creation of long-term value by providing strategic capital to enhance employee retention, facilitate business development, buy out legacy equity holders and generate strategic options – while preserving the autonomy and entrepreneurial spirit of these organizations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319748099/en/
Peter Tornatore
Phone: 206.600.1251
Email: peter.tornatore@frazierhealthcare.com
Carol Eckert
Phone: 206.600.1151
Email: carol.eckert@frazierhealthcare.com
Source: Frazier Healthcare Partners
FAQ
What is the size of Frazier Healthcare Partners' latest fund (FHGB XI)?
How will Goldman Sachs' Petershill investment impact Frazier Healthcare Partners' operations?
How many companies has Frazier Healthcare Partners invested in since its founding?
What are the terms of Goldman Sachs Petershill's investment in Frazier Healthcare Partners?
